Prospective, multicenter trial will evaluate a novel preservation technique utilizing the Paragonix SherpaPak® for DCD (Donation after Circulatory Death) hearts. Paragonix Technologies and UW Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results